Evidence map›Paper›PMID 33976959›Full record

ArticlePeerJ2021

Diabetic kidney disease in type 2 diabetes: a review of pathogenic mechanisms, patient-related factors and therapeutic options.

Louise Woodhams, Tin Fei Sim, Leanne Chalmers, Bu Yeap, Daniel Green, Markus Schlaich, Carl Schultz, Graham Hillis

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in PeerJ, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Guideline
  2. Review
  3. Review
  4. Pathomechanisms of Diabetic Kidney Disease.Journal of clinical medicine · 2023
    Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Louise WoodhamsCurtin Medical School, Curtin University of Technology, Perth, Western Australia, Australia.
Tin Fei SimCurtin Medical School, Curtin University of Technology, Perth, Western Australia, Australia.
Leanne ChalmersCurtin Medical School, Curtin University of Technology, Perth, Western Australia, Australia.
Bu YeapDepartment of Endocrinology and Diabetes, Fiona Stanley Hospital, Perth, Western Australia, Australia.
Daniel GreenSchool of Human Sciences (Exercise and Sport Sciences), The University of Western Australia, Perth, Western Australia, Australia.
Markus SchlaichMedical School, The University of Western Australia, Perth, Western Australia, Australia.
Carl SchultzMedical School, The University of Western Australia, Perth, Western Australia, Australia.
Graham HillisMedical School, The University of Western Australia, Perth, Western Australia, Australia.
Curtin University · AURoyal Perth Hospital · AUUniversity of Western Australia · AUFiona Stanley Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The global prevalence of diabetic kidney disease is rapidly accelerating due to an increasing number of people living with type 2 diabetes. It has become a significant global problem, increasing human and financial pressures on already overburdened healthcare systems. Interest in diabetic kidney disease has increased over the last decade and progress has been made in determining the pathogenic mechanisms and patient-related factors involved in the development and pathogenesis of this disease. A greater understanding of these factors will catalyse the development of novel treatments and influence current practice. This review summarises the latest evidence for the factors involved in the development and progression of diabetic kidney disease, which will inform better management strategies targeting such factors to improve therapeutic outcomes in patients living with diabetes.

Indexed as

Diabetic kidney diseasePathogenesisRisk factorsType 2 Diabetes Mellitus

Identifiers

PMID33976959
PMCPMC8061574
OpenAlexW3156871218

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.